Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us.
Metab Syndr Relat Disord
; 20(3): 137-140, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1598386
ABSTRACT
As the world enters its third year of the COVID-19 pandemic, individuals with diabetes have faced particular challenges from the virus. A deleterious bidirectional relationship exists between the two disorders, with heightened inflammatory, immunologic, and cellular mechanisms leading to a more severe illness and increased morbidity and mortality. Tight glucose control, though necessary, is hampered by physical restrictions and difficulty accessing health care. Novel glucose-lowering medications may provide unique benefits in this regard. It is imperative that multi-pronged efforts be prioritized in order to reduce adverse outcomes in patients with diabetes at risk for COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Metab Syndr Relat Disord
Journal subject:
Metabolism
Year:
2022
Document Type:
Article
Affiliation country:
Met.2021.0133
Similar
MEDLINE
...
LILACS
LIS